Abstract: Clinical Infection in Practice 13 (2022) 100137
Contents lists available at ScienceDirect
Clinical Infection in Practice
journal homepage: www.sciencedirect.com/journal/clinical-infection-in-practice
Case Reports and Series
Higher mortality of hospitalized haematologic patients with COVID-19
compared to non-haematologic is driven by thrombotic complications and
development of ARDS: An age-matched cohorts study☆
Ana Fernández-Cruz a, g, *, Alba Puyuelo b, Lucía Núñez Martín-Buitrago b, Enrique SánchezChica c, Carmen Díaz-Pedroche d, h, j, Rosa Ayala e, h, Manuel Lizasoain f, h, Rafael Duarte b, g, i,
Carlos Lumbreras f, h, j, Juan Antonio Vargas c, g, i
a
Infectious Diseases Department, Hospital Puerta de Hierro-Majadahonda, Madrid, Spain
Haematology Department, Hospital Puerta de Hierro-Majadahonda, Madrid, Spain
c
Internal Medicine Department, Hospital Puerta de Hierro-Majadahonda, Madrid, Spain
d
Internal Medicine Department, Hospital Doce de Octubre, Madrid, Spain
e
Haematology Department, Hospital Doce de Octubre, Madrid, Spain
f
Infectious Diseases Department, Hospital Doce de Octubre, Madrid, Spain
g
Fundación de Investigación Sanitaria Puerta de Hierro - Segovia de Arana, Spain
h
Fundación para la Investigación Biomédica del Hospital Universitario, 12 de Octubre, Spain
i
Universidad Autónoma de Madrid, Spain
j
Universidad Complutense de Madrid, Spain
b
A R T I C L E I N F O
A B S T R A C T
Keywords
COVID-19
Haematologic
Outcome
Mortality
Background and Objectives: The characteristics of COVID-19 in haematologic patients compared to nonhaematologic patients have seldom been analyzed. Our aim was to analyze whether there are differences in
clinical characteristics and outcome of haematologic patients with COVID-19 as compared to non-haematologic.
Patients and methods: Retrospective cohort study in 2 University hospitals of patients admitted with laboratoryconfirmed COVID-19 included in the SEMICOVID19 database. The cohort with underlying haematologic disease
was compared to a cohort of age and date-of-COVID-19-matched controls without haematologic disease (1:2).
Results: 71 cases and 142 controls were included from March-May 2020.
Twenty (28.1%) had received recent chemotherapy. Twelve (16.9%) were stem cell transplant recipients (SCT).
Eleven (15.5%) were neutropenic concurrently with COVID-19 diagnosis.
Haematologic patients presented ARDS (58.5 vs 20.7%, p = 0.0001), thrombotic complications (15.7 vs 2.1%, p
= 0.002), DIC (5.7 vs 0.0%, p = 0.011), heart failure (14.3 vs 4.9%, p = 0.029) and required ICU admission (15.5
vs 2.8%, p = 0.001), MV (14.1% vs 2.1%, p 0.001), steroid (64.8 vs 33.1%, p = 0.0001), tocilizumab (33.8 vs
8.5%, p = 0.0001) or anakinra treatment (9.9% vs 0%, p = 0.0001) more often. In-hospital mortality was
significantly higher (38.0% vs 18.3%, p = 0.002).
Conclusions: Our results suggest COVID-19 has worse outcomes in haematologic patients than in nonhaematologic, independently of age, and that the development of ARDS and thrombotic complications drive
the higher in-hospital mortality.
Abbreviations: ARDS, acute respiratory distress syndrome; C-RP, C-reactive protein; CI, confidence interval; CLL, chronic lymphocytic leukemia; COVID-19,
Coronavirus disease 2019; DIC, disseminated intravascular coagulation; ECOG scale, Eastern Cooperative Oncology Group scale; G-CSF, granulocyte stimulating
factor; HFNC, high flow nasal cannula; ICU, Intensive Care Unit; IL6, Interleukin 6; IQR,..
DOI record:
{
  "DOI": "10.1016/j.clinpr.2022.100137",
  "ISSN": [
    "2590-1702"
  ],
  "URL": "http://dx.doi.org/10.1016/j.clinpr.2022.100137",
  "alternative-id": [
    "S259017022200005X"
  ],
  "article-number": "100137",
  "author": [
    {
      "affiliation": [],
      "family": "Fernández-Cruz",
      "given": "Ana",
      "sequence": "first"
    },
    {
      "affiliation": [],
      "family": "Puyuelo",
      "given": "Alba",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Núñez Martín-Buitrago",
      "given": "Lucía",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Sánchez-Chica",
      "given": "Enrique",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Díaz-Pedroche",
      "given": "Carmen",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Ayala",
      "given": "Rosa",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Lizasoain",
      "given": "Manuel",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Duarte",
      "given": "Rafael",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Lumbreras",
      "given": "Carlos",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Antonio Vargas",
      "given": "Juan",
      "sequence": "additional"
    }
  ],
  "container-title": "Clinical Infection in Practice",
  "container-title-short": "Clinical Infection in Practice",
  "content-domain": {
    "crossmark-restriction": false,
    "domain": []
  },
  "created": {
    "date-parts": [
      [
        2022,
        2,
        15
      ]
    ],
    "date-time": "2022-02-15T03:43:08Z",
    "timestamp": 1644896588000
  },
  "deposited": {
    "date-parts": [
      [
        2022,
        4,
        22
      ]
    ],
    "date-time": "2022-04-22T23:04:49Z",
    "timestamp": 1650668689000
  },
  "indexed": {
    "date-parts": [
      [
        2022,
        4,
        22
      ]
    ],
    "date-time": "2022-04-22T23:41:45Z",
    "timestamp": 1650670905449
  },
  "is-referenced-by-count": 0,
  "issued": {
    "date-parts": [
      [
        2022,
        1
      ]
    ]
  },
  "language": "en",
  "license": [
    {
      "URL": "https://www.elsevier.com/tdm/userlicense/1.0/",
      "content-version": "tdm",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2022,
            1,
            1
          ]
        ],
        "date-time": "2022-01-01T00:00:00Z",
        "timestamp": 1640995200000
      }
    },
    {
      "URL": "http://creativecommons.org/licenses/by-nc-nd/4.0/",
      "content-version": "vor",
      "delay-in-days": 40,
      "start": {
        "date-parts": [
          [
            2022,
            2,
            10
          ]
        ],
        "date-time": "2022-02-10T00:00:00Z",
        "timestamp": 1644451200000
      }
    }
  ],
  "link": [
    {
      "URL": "https://api.elsevier.com/content/article/PII:S259017022200005X?httpAccept=text/xml",
      "content-type": "text/xml",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "https://api.elsevier.com/content/article/PII:S259017022200005X?httpAccept=text/plain",
      "content-type": "text/plain",
      "content-version": "vor",
      "intended-application": "text-mining"
    }
  ],
  "member": "78",
  "original-title": [],
  "page": "100137",
  "prefix": "10.1016",
  "published": {
    "date-parts": [
      [
        2022,
        1
      ]
    ]
  },
  "published-print": {
    "date-parts": [
      [
        2022,
        1
      ]
    ]
  },
  "publisher": "Elsevier BV",
  "reference": [
    {
      "DOI": "10.1016/j.bbmt.2015.11.015",
      "article-title": "Outcomes of Influenza Infections in Hematopoietic Cell Transplant Recipients: Application of an Immunodeficiency Scoring Index",
      "author": "Kmeid",
      "doi-asserted-by": "crossref",
      "first-page": "542",
      "issue": "3",
      "journal-title": "Biol Blood Marrow Transplant",
      "key": "10.1016/j.clinpr.2022.100137_b0005",
      "volume": "22",
      "year": "2016"
    },
    {
      "DOI": "10.1111/tid.13105",
      "article-title": "Refinement of estimates of mortality risk using the Radiologic Severity Index in hematologic malignancy patients with respiratory syncytial virus infection",
      "author": "Sheshadri",
      "doi-asserted-by": "crossref",
      "issue": "4",
      "journal-title": "Transpl Infect Dis",
      "key": "10.1016/j.clinpr.2022.100137_b0010",
      "volume": "21",
      "year": "2019"
    },
    {
      "DOI": "10.1093/cid/ciaa1079",
      "article-title": "Are All Patients with Cancer at Heightened Risk for Severe Coronavirus Disease 2019 (COVID-19)?",
      "author": "Chamilos",
      "doi-asserted-by": "crossref",
      "first-page": "351",
      "issue": "2",
      "journal-title": "Clin Infect Dis",
      "key": "10.1016/j.clinpr.2022.100137_b0015",
      "volume": "72",
      "year": "2021"
    },
    {
      "DOI": "10.1186/s13045-020-00970-7",
      "article-title": "Impact of hematologic malignancy and type of cancer therapy on COVID-19 severity and mortality: lessons from a large population-based registry study",
      "author": "García-Suárez",
      "doi-asserted-by": "crossref",
      "issue": "1",
      "journal-title": "J Hematol Oncol",
      "key": "10.1016/j.clinpr.2022.100137_b0020",
      "volume": "13",
      "year": "2020"
    },
    {
      "DOI": "10.1016/S2352-3026(20)30251-9",
      "article-title": "Clinical characteristics and risk factors associated with COVID-19 severity in patients with haematological malignancies in Italy: a retrospective, multicentre, cohort study",
      "author": "Passamonti",
      "doi-asserted-by": "crossref",
      "first-page": "e737",
      "issue": "10",
      "journal-title": "Lancet Haematol",
      "key": "10.1016/j.clinpr.2022.100137_b0025",
      "volume": "7",
      "year": "2020"
    },
    {
      "DOI": "10.1016/j.rce.2020.07.003",
      "article-title": "Clinical characteristics of patients hospitalized with COVID-19 in Spain: Results from the SEMI-COVID-19 Registry",
      "author": "Casas-Rojo",
      "doi-asserted-by": "crossref",
      "first-page": "480",
      "issue": "8",
      "journal-title": "Rev Clin Esp",
      "key": "10.1016/j.clinpr.2022.100137_b0030",
      "volume": "220",
      "year": "2020"
    },
    {
      "DOI": "10.1182/blood-2016-08-733196",
      "article-title": "Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel",
      "author": "Döhner",
      "doi-asserted-by": "crossref",
      "first-page": "424",
      "issue": "4",
      "journal-title": "Blood",
      "key": "10.1016/j.clinpr.2022.100137_b0035",
      "volume": "129",
      "year": "2017"
    },
    {
      "DOI": "10.1200/JCO.2013.54.8800",
      "article-title": "Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification",
      "author": "Cheson",
      "doi-asserted-by": "crossref",
      "first-page": "3059",
      "issue": "27",
      "journal-title": "J Clin Oncol",
      "key": "10.1016/j.clinpr.2022.100137_b0040",
      "volume": "32",
      "year": "2014"
    },
    {
      "DOI": "10.1016/S1470-2045(16)30206-6",
      "article-title": "International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma",
      "author": "Kumar",
      "doi-asserted-by": "crossref",
      "first-page": "e328",
      "issue": "8",
      "journal-title": "Lancet Oncol",
      "key": "10.1016/j.clinpr.2022.100137_b0045",
      "volume": "17",
      "year": "2016"
    },
    {
      "DOI": "10.1097/00000421-198212000-00014",
      "article-title": "Toxicity and response criteria of the Eastern Cooperative Oncology Group",
      "author": "Oken",
      "doi-asserted-by": "crossref",
      "first-page": "649",
      "issue": "6",
      "journal-title": "AMERICAN JOURNAL OF CLINICAL ONCOLOGY",
      "key": "10.1016/j.clinpr.2022.100137_b0050",
      "volume": "5",
      "year": "1982"
    },
    {
      "article-title": "Acute respiratory distress syndrome: the Berlin Definition",
      "author": "Force",
      "first-page": "2526",
      "issue": "23",
      "journal-title": "JAMA",
      "key": "10.1016/j.clinpr.2022.100137_b0055",
      "volume": "307",
      "year": "2012"
    },
    {
      "DOI": "10.1097/MD.0000000000025634",
      "article-title": "Major determinants of death in patients hospitalized with COVID-19 during the first epidemic wave in Madrid, Spain",
      "author": "Moreno-Torres",
      "doi-asserted-by": "crossref",
      "first-page": "e25634",
      "issue": "16",
      "journal-title": "Medicine (Baltimore)",
      "key": "10.1016/j.clinpr.2022.100137_b0060",
      "volume": "100",
      "year": "2021"
    },
    {
      "DOI": "10.1016/S2213-2600(21)00218-6",
      "article-title": "The COVID-19 puzzle: deciphering pathophysiology and phenotypes of a new disease entity",
      "author": "Osuchowski",
      "doi-asserted-by": "crossref",
      "first-page": "622",
      "issue": "6",
      "journal-title": "Lancet Respir Med",
      "key": "10.1016/j.clinpr.2022.100137_b0065",
      "volume": "9",
      "year": "2021"
    },
    {
      "DOI": "10.1186/cc8149",
      "article-title": "Risk factors for acute respiratory distress syndrome during neutropenia recovery in patients with hematologic malignancies",
      "author": "Rhee",
      "doi-asserted-by": "crossref",
      "first-page": "R173",
      "issue": "6",
      "journal-title": "Crit Care",
      "key": "10.1016/j.clinpr.2022.100137_b0070",
      "volume": "13",
      "year": "2009"
    },
    {
      "DOI": "10.1111/tid.13606",
      "article-title": "Immune reconstitution and severity of COVID‐19 among hematopoietic cell transplant recipients",
      "author": "Malek",
      "doi-asserted-by": "crossref",
      "issue": "4",
      "journal-title": "Transpl Infect Dis",
      "key": "10.1016/j.clinpr.2022.100137_b0075",
      "volume": "23",
      "year": "2021"
    },
    {
      "DOI": "10.1080/10428194.2018.1516874",
      "article-title": "Granulocyte colony-stimulating factor and respiratory status of critically ill neutropenic patients with hematologic malignancies",
      "author": "Mignard",
      "doi-asserted-by": "crossref",
      "first-page": "1156",
      "issue": "5",
      "journal-title": "Leuk Lymphoma",
      "key": "10.1016/j.clinpr.2022.100137_b0080",
      "volume": "60",
      "year": "2019"
    },
    {
      "DOI": "10.1038/s41577-021-00536-9",
      "article-title": "Endothelial dysfunction and immunothrombosis as key pathogenic mechanisms in COVID-19",
      "author": "Bonaventura",
      "doi-asserted-by": "crossref",
      "first-page": "319",
      "issue": "5",
      "journal-title": "Nat Rev Immunol",
      "key": "10.1016/j.clinpr.2022.100137_b0085",
      "volume": "21",
      "year": "2021"
    },
    {
      "DOI": "10.1007/s00134-021-06419-w",
      "article-title": "Pulmonary immuno-thrombosis in COVID-19 ARDS pathogenesis",
      "author": "O'Donnell",
      "doi-asserted-by": "crossref",
      "first-page": "899",
      "issue": "8",
      "journal-title": "Intensive Care Med",
      "key": "10.1016/j.clinpr.2022.100137_b0090",
      "volume": "47",
      "year": "2021"
    },
    {
      "DOI": "10.1016/j.blre.2018.06.002",
      "article-title": "Venous thromboembolism incidence in hematologic malignancies",
      "author": "Kekre",
      "doi-asserted-by": "crossref",
      "first-page": "24",
      "journal-title": "Blood Rev",
      "key": "10.1016/j.clinpr.2022.100137_b0095",
      "volume": "33",
      "year": "2019"
    },
    {
      "DOI": "10.1016/j.jhin.2021.02.014",
      "article-title": "Duration of isolation and precautions in immunocompromised patients with COVID-19",
      "author": "Taramasso",
      "doi-asserted-by": "crossref",
      "first-page": "202",
      "journal-title": "J Hosp Infect",
      "key": "10.1016/j.clinpr.2022.100137_b0100",
      "volume": "111",
      "year": "2021"
    },
    {
      "DOI": "10.1186/s40164-020-00177-z",
      "article-title": "Risk factors and outcome of COVID-19 in patients with hematological malignancies",
      "author": "Piñana",
      "doi-asserted-by": "crossref",
      "issue": "1",
      "journal-title": "Exp Hematol Oncol",
      "key": "10.1016/j.clinpr.2022.100137_b0105",
      "volume": "9",
      "year": "2020"
    },
    {
      "DOI": "10.1111/tid.13401",
      "article-title": "Severe COVID-19 in a patient with chronic graft-versus-host disease after hematopoietic stem cell transplant successfully treated with ruxolitinib",
      "author": "Saraceni",
      "doi-asserted-by": "crossref",
      "issue": "1",
      "journal-title": "Transpl Infect Dis",
      "key": "10.1016/j.clinpr.2022.100137_b0110",
      "volume": "23",
      "year": "2021"
    },
    {
      "DOI": "10.1016/j.cegh.2021.100755",
      "article-title": "The use of Janus Kinase inhibitors in hospitalized patients with COVID-19: Systematic review and meta-analysis",
      "author": "Wijaya",
      "doi-asserted-by": "crossref",
      "first-page": "100755",
      "journal-title": "Clin Epidemiol Glob Health",
      "key": "10.1016/j.clinpr.2022.100137_b0115",
      "volume": "11",
      "year": "2021"
    },
    {
      "article-title": "BTK inhibitors for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): A Systematic Review",
      "author": "Stack",
      "journal-title": "Res Sq",
      "key": "10.1016/j.clinpr.2022.100137_b0120",
      "year": "2021"
    },
    {
      "DOI": "10.1016/j.ejca.2021.01.033",
      "article-title": "2021 update of the AGIHO guideline on evidence-based management of COVID-19 in patients with cancer regarding diagnostics, viral shedding, vaccination and therapy",
      "author": "Giesen",
      "doi-asserted-by": "crossref",
      "first-page": "154",
      "journal-title": "Eur J Cancer",
      "key": "10.1016/j.clinpr.2022.100137_b0125",
      "volume": "147",
      "year": "2021"
    }
  ],
  "reference-count": 25,
  "references-count": 25,
  "relation": {},
  "resource": {
    "primary": {
      "URL": "https://linkinghub.elsevier.com/retrieve/pii/S259017022200005X"
    }
  },
  "score": 1,
  "short-title": [],
  "source": "Crossref",
  "subject": [
    "General Medicine"
  ],
  "subtitle": [],
  "title": "Higher mortality of hospitalized haematologic patients with COVID-19 compared to non-haematologic is driven by thrombotic complications and development of ARDS: An age-matched cohorts study",
  "type": "journal-article",
  "volume": "13"
}